"Sodium Glucose Cotransporter 2 Inhibition Heralds a Call-to-Action for Diabetic Kidney Disease." by Katherine Tuttle

Selected Works of Katherine R. Tuttle, MD, FASN, FACP, FNKF

Follow Contact

Article

Sodium Glucose Cotransporter 2 Inhibition Heralds a Call-to-Action for Diabetic Kidney Disease.

Clin J Am Soc Nephrol

Katherine Tuttle, Providence Medical Research Center, Providence Health Care, Spokane, Washington
David Z Cherney
Diabetic Kidney Disease Task Force of the American Society of Nephrology

Link

Document Type

Article

Publication Date

2-7-2020

Keywords

washington,
spokane

Disciplines

Endocrinology, Diabetes, and Metabolism and
Nephrology

Clinical Institute

Kidney & Diabetes

Specialty

Endocrinology

Specialty

Nephrology

Citation Information

Katherine Tuttle, David Z Cherney and Diabetic Kidney Disease Task Force of the American Society of Nephrology. "Sodium Glucose Cotransporter 2 Inhibition Heralds a Call-to-Action for Diabetic Kidney Disease." Clin J Am Soc Nephrol (2020)
Available at: http://works.bepress.com/katherine-tuttle/360/